Possibilities of a viral etiology for human breast cancer: A review

Biological Trace Element Research

Volumn 56, Issue 1, 1997, Pages 131-142

  Pogo, Beatriz G T ^a,b   Holland, James F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Breast cancer; retroviral sequences

Indexed keywords

DNA;

BREAST CANCER; CONFERENCE PAPER; DNA SEQUENCE; GENE EXPRESSION; HUMAN; MOLECULAR CLONING; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING;

HUMAN ENDOGENOUS RETROVIRUSES; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; ONCOVIRINAE; TUMOR VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0030965141     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02778989     Document Type: Conference Paper

References (83)

1. Y. Miki, J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, et al., A strong candidate for the breast and ovarian cancer susceptibility Gene BRCA1. Science 266, 66-71 (1994).
2. R. Wooster, S. L. Neuhausen, J. Mangion, Y. Quirk, D. Ford, et al., Localization of a breast cancer susceptibility gene BRCA2, chromosome 13q12-13. Science 265, 2088-2090 (1994).
3. K. Hoskins and F. L. Weber, Recent advances in breast cancer biology. Curr. Opinion Oncol. 7, 495-500 (1995).
4. Y. Chen, C-F Chen, D. J. Riley, D. C. Allred, P-L Chen, D. Von Hoff, C. K. Osborne, and W-H Lee, Aberrant Subcellular localization of BRCA-1 in breast cancer. Science 270, 789-791 (1995).
5. N. Collins, R. McManus, R. Wooster, J. Mangion, S. Seal, S. R. Lakhani, W. Orminston, P. A. Daly, D. Ford, D. F. Easton, and M. R. Stratton, Oncogene 10, 1673-1675 (1995).
6. R. A. Jensen, M. E. Thompson, T. L. Jetton, C. I. Szabo, R. van der Meer, B. Helou, S. R. Tronick, D. L. Page, M-C King, and J. T. Holt, BRCA1 is secreted and exhibits properties of a granin, Nature Genet. 12, 303-308 (1996).
7. I. Bieche, M. H. Champene, D. Matifas, C. Cropp, R. Callahan, and R. Lidereau, Maintenance of p53 alterations throughout breast cancer progression. Cancer Res. 53, 1990-199 (1993).
8. A. M. Davidoff, B-J M. Kerns, J. D. Iglehart, and J. R. Marks, Maintenance of p53 alterations throughout breast cancer progression. Cancer Res. 51, 2605-2610 (1991).
9. D. J. Slamon, W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 244, 707-712 (1989).
10. D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182 (1987).
11. G. Casey, R. Smith, D. McGillivray, G. Peters, and C. Dickson, Characterization and chromosome assignments of the human homolog of int-2, a potential protooncogene. Mol. and Cell. Biol. 6, 502-510 (1986).
12. R. Lidereau, R. Callahan, C. Dickson, G. Peters, C. Escot, and I. U. Ali, Amplification of the int-2 gene in primary human breast tumors. Oncogene Res. 2, 285-291 (1988).
13. D. J. Zhou, G. Casey, and M. J. Cline, Amplification of human int-2 in breast cancers and squamous carcinomas. Oncogene 2, 279-282 (1988).
14. D. S. Liscia, G. R. Merlo, C. Garrett, D. French, R. Marini-Constantini, and R. Callahan, Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Oncogene 4, 1219-1224 (1989).
15. Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, R., Arnold, A., and Peters, G., D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1, Oncogene 6, 439-444 (1991).
16. M. C. Yoshida, M. Wada, H. Satoh, T. Yoshida, H. Sakamoto, K. Miyagawa, J. Yokota, T. Koda, M. Kakinuma, T. Sugimura, and M. Terada, Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the 1NT2 gene in human cancer. Proc. Natl. Acad. Sci. USA 85, 4861-4864 (1988).
17. M. F. Buckley, K. J. E. Sweeney, J. A. Hamilton, R. L. Sini, D. L. Manning, R. I. Nicholson, A. de Fazio, C. K. W. Watts, E. A. Musgrove, and R. L. Sutherland, Expression and Amplification of cyclin genes in human breast cancer. Oncogene 8, 2127-2133 (1983).
18. D. Weinstat-Saslow, M. J. Merino, R. E. Manrow, J. A. Lawrence, R. F. Bluth, K. D. Winttenbel, J. F. Simpson, D. L. Page, and P. S. Steeg, Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1, 1257-1260 (1995).
19. S. Lejeune, E. L. Huguet, A. Hamby, R. Poulsom, and A. L. Harris, WntSa cloning, expression and up-regulation in human primary breast cancer. Clin. Cancer Res. 1, 215-222 (1995).
20. V. Papa, F. Gliozzo, G. M. Clark, W. L. McGuire, D. Moore, F-Y Yoko, R. Vigneri, I. D. Goldfine, and V. Pezzino, Insulin growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Research 53, 3736-3740 (1993).
21. R. Pelligrini, S. Martignone, E. Tagliabue, D. Belotti, R. Bufalino, N. Cascinelli, S. Menard, and M. I. Colnaghi, Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas. Breast Cancer Res. and Treatment 35, 195-199 (1995).
22. M. M. Zutter, S. A. Santoro, W. D. Staatz, and Y. L. Tsung, Reexpression of the α2β1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA 92, 7411-7415 (1995).
23. M. A. Schwartz, Signaling by integrins. Cancer Res. 53, 1503-1506 (1993).
24. J. R. Graff, J. G. Herman, R. G. Lapidus, H. Chopra, R. Xu, D. F. Jarrad, W. B. Isaacs, P. M. Pitha, N. E. Davidson, and S. B. Baylin, E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Research 55, 5195-5199 (1995).
25. T. Sato, H. Saito, J. Swensen, A. Olifant, C. Wood, D. Danner, T. Sakamoto, K. Takita, F. Kasumi, Y. Miki, M. Skolnick, and Y. Nakamura, The human prohibitin gene located on chromosone 17q21 is mutated in sporadic breast cancer. Cancer Res. 52, 1643-1646 (1992).
26. E. Larsson, N. Kato, and M. Cohen, Human Endogenous Provinsses. Curr. Top. Microbiol. Immunol. 148, 115-132 (1989).
27. C. Leib-Mosch, R. Brack-Werner, T. Werner, M. Bachman, O. Faff, V. Erfle, and R. Hehlmann, Endogenous retroviral elements in human DNA. Cancer Res. (Suppl.) 50, 5636s-5642s (1990).
28. M. Ono, M. Kawakami, and H. Ushikuo, Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J. Virol. 61, 2059-2062 (1987).
29. B. R. Westley and F. E. B. May, Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res. 15, 3773-3786 (1987).
30. G. C. Franklin, S. Chretien, I. M. Hanson, H. Rochefort, F. E. B. May, and B. R. Westley, Expression of human sequences related to those of mouse mammary tumor virus. J. Virol. 62, 1203-1210 (1988).
31. P. Medstrand, M. Linkeskog, and J. J. Blomberg, Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals, Gen. Virol. 73, 2463-2466, (1992).
32. I. Brodsky, B. Foley, D. Haines, J. Johnston, and D. Gillispie, Expression of HERV-K provirus in human leukocytes, Blood 81, 2369-2374 (1993).
33. M. Simon, M. Haltmeier, G. Papakonstatinou, T. Werner, R. Hehlmann, and C. Leib-Mosch, Transcription of Herv-K-related LTR's in human placenta and leukemic cells, Leukemia Suppl. V8, suppl. S12-S17 (1994).
34. R. Lower, J. Lower, C. Tondera-Koch, and R. Kurth, A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells, Virology 192, 501-511 (1993).
35. K. P. Medstrand and J. Blomberg, Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: Differential transcription in normal human tissues, J. Virol. 67, 6778-6787 (1993).
36. D. G. Poirier, J. Poley, K. Cuddy, I. Brodsky, J. Brodsky, and D. Gillispie, Independent expression of int-2 mRNA and HERV-K env mRNA in human breast tumors. Abstract in Proc. Am. Assoc. Cancer Res. 35, 549 (1994).
37. M. Sauter, S. Schommer, E. Kremmer, K. Remberger, G. Dolken, I. Lemm, M. Buck, B. Best, D. Neumann-Haefelin, and N. Mueller-Lantzsch, Human endogenous retrovirus K10: expression of gag protein and detection of antibodies in patients with seminomas, J. Virol. 69, 414-121 (1995).
38. N. L. DiFronzo and C. A. Holland, A direct demonstration of recombination between an injected virus and endogenous viral sequences, resulting in the generation of mink cell focus inducing viruses in AKR mice, J. Virol. 67, 3763-3770 (1993).
39. T. Golovkina, A. B. Jaffe, and S. R. Ross, Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range, J. Virol. 68, 5019-5026 (1994).
40. T. Tchenio and T. Heidmann, Defective retrovirus can disperse in the human genome by intracellular transposition, J. Virol. 65, 2113-2118 (1991).
41. S. Imai, M. Okumoto, M. Iwai, S. Haga, N. Mori, N. Miyashita, K. Moriwaki, J. Hilgers, and N. H. Sarkar, Distribution of mouse mammary tumor virus in asian wild mice, J. Virol. 68, 3437-3442 (1994).
42. R. Nusse, Insertional mutagenesis in mouse mammary tumorigenesis, Curr. Top. Microbiol. Immunol. 171, 43-65 (1991).
43. A. Marchetti, Buttitta, S. Miyazaki, D. Gallahan, G. H. Smith, and R. Callahan, Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors, J. Virol. 69, 1932-1938 (1995).
44. G. Peters, S. Brookers, R. Smith, and C. Dickson, Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors, Cell 33, 369-377 (1983).
45. G. M. Shackleford, C. A. MacArthur, H. C. Kwan, and H. E. Varmus, Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4, Proc. Natl. Acad. Sci. USA 90, 740-744 (1993).
46. C. A. MacArthur, D. A. Shankar, and G. M. Shackleford, Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis, J. Virol. 69, 2501-2507 (1995).
47. S-I Yanagawa, K. Kakimi, H. Tanaka, A. Murakami, Y. Nakagawa, Y. Kubo, Y. Yamada, H. Hiai, K. Kuribayashi, T. Masuda, and A. Ishimoto, Identification of a novel mammary cell line-specific enhancer element in the long terminal repeat of mouse mammary tumor virus, which interacts with its hormone-responsive element, J. Virol. 67, 112-118 (1993).
48. P. Marrack, E. Kushnir, and J. Kappler, A maternally inherited superantigen encoded by a mammary tumor virus, Nature 349, 524-526 (1991).
49. W. Held, G. A. Waanders, H. Acha-Orbea, and H. R. MacDonald, Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function, J. Exp. Med. 180, 2347-2351 (1994).
50. R. Mukhopadhyay, M. Medina, and J. S. Butel, Expression of the mouse mammary tumor virus long terminal repeat open reading frame promotes tumorigenic potential of hyperplastic mouse mammary epithelial cells, Virology 211, 84-93 (1995).
51. A. S. Dion, Retrovirus association with breast cancer: A critical appraisal, Breast Cancer Res. and Treatment 9, 155-156 (1987).
52. R. Mesa-Tejada, I. Keydar, M. Ramanarayanan, T. Ohno, C. Fenoglio, and S. Spiegelman, Detection in human breast carcinomas of an antigen mmunologically related to a group-specific antigen of mouse mammary tumor virus, Proc. Natl. Acad. Sci. USA 75, 1529-1533 (1978).
53. P. Levine, N. Mourali, F. Tabbave, J. Costa, R. Mesa-Tejada, S. Spiegelman, and J. G. Bekesi, Immunopathologic features of rapidly progressing breast cancer (RPBC) in Tunisia, Proc. Am. Assoc. Cancer Res. 21, 170 (1980).
54. R. Lloyd, P. P. Rosen, N. H. Sarkar, D. Jimenez, D. W. Kinne, C. Menendez-Botet, and M. K. Schwartz, Murine mammary tumor virus related antigen in human male mammary carcinoma, Cancer 51, 654-661 (1983).
55. S. V. Litvinov and T. V. Golovkina, Expression of proteins immunologically related to murine mammary tumour virus (MMTV) core proteins in the cells of breast cancer continuous lines MCF-7, T47D, MDA-231 and cells from human milk, Acta Virologica 33, 137-142 (1989).
56. S. Zotter, C. Kemmer, A. Lossnitzer, H. Grossmann, and B. A. Johannsen, Mouse mammary tumour virus-related antigens in core-like density fractions from large samples of women's milk, Eur. J. Cancer 16, 455-467 (1980).
57. N. K. Day, S. S. Witkin, N. H. Sarkar, D. Kinne, D. J. Jussawalla, A. Levin, C. C. Hsia, N. Geller, and R. A. Good, Antibodies reactive with murine mammary tumor virus in sera of patients with breast cancer: Geographic and family studies, Proc. Natl. Acad. Sci. USA 78, 2483-2487 (1981).
58. A. Segal-Eiras, M. V. Croce, and Chr. D. Pasqualini, Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients, Arch. Geschwulstforsch. 53, 321-327 (1983).
59. S. S. Witkin, N. H. Sarkar, D. W. Kinne, C. N. Breed, R. A. Good, and N. K. Day, Antigens and antibodies cross-reactive to the murine mammary tumor virus in human breast cyst fluids, J. Clin. Invest. 67, 216-222 (1981).
60. I. Keydar, T. Ohno, R. Nayak, R. Sweet, F. Simoni, F. Weiss, S. Karby, R. Mesa-Tejada, and S. Spiegelman, Properties of retrovirus-like particles produced by a human breast carcinoma cell line: Immunological relationship with mouse mammary tumor virus proteins, Proc. Natl. Acad. Sci. USA 81, 4188-4192 (1984).
61. D. de Ricqles, A. Olomucki, F. Gosselin, and R. Ridereau, Breast cancer and T-cell-mediated immunityt to proteins of the mouse mammary tumour virus (MMTV), Eur. Cytokine Netw. 4, 153-160, (1993).
62. R. Callahan, W. Drohan, S. Tronick, and J. Schlom, Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome, Proc. Natl. Acad. Sci. USA 79, 5503-5507 (1982).
63. R. Axel, J. Schlom, and S. Spiegelman, Presence in human breast cancer of RNA homologous to mouse mammary tumor virus RNA, Nature 235, 32-36 (1972).
64. M. Crepin, R. Lidereau, J. C. Chermann, P. Pouillart, H. Magdamenat, and L. Montagnier, Sequences related to mouse mammary tumor virus genome in tumor cells and lymphocytes from patients with breast cancer, Biochem. Biophysic. Ress. Commun. 118, 324-331 (1984).
65. A. M. Al-Sumidaie, C. A. Hart, S. J. Leinster, and C. D. Green, Particles with properties of retroviruses in monocytes from patients with breast cancer, Lancet 1, 5-8 (1988).
66. C. M. McGrath, P. M. Grant, H. D. Soule, T. Glancy, and M. A. Rich, Replication of oncornavirus-like particle in human breast carcinoma cell line MCF-7, Nature 252, 247-250 (1972).
67. B. Westley and F. E. B. May, The human genome contains multiple sequences of varying homology to mouse mammary tumour virus DNA, Gene 28, 221-227 (1984).
68. M. Ono, T. Yasunaga, T. Miyata, and H. Ushikubo, Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome, J. Virol 60, 589-598 (1986).
69. O. Faff, A. B. Murray, J. Schmidt, C. Leib-Mosch, V. Erfle, and R. Hehlmann, Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumor virus and are of endogenous origin, J. Gen. Virol. 73, 1087-1097 (1992).
70. M. Hareuveni and R. Lathe, Breast cancer sequences identified by mouse mammary tumor virus (MMTV) antiserum are unrelated to MMTV, Int. J. Cancer 46, 1134-1135 (1990).
71. F. E. B. May and B. R. Westley, Characterization of sequences related to the mouse mammary tumor virus that are specific to MCF-7 breast cancer cells, Cancer Res. 49, 3879-3883 (1989).
72. J. G. Szakaacs and L. C. Moscinski, Sequence homology of deoxyribonucleic acid to mouse mammary tumor virus genome in human breast tumors, Ann. Clin. Lab. Sci. 21, 402-412 (1991).
73. S. L. Meyers, M. T. O'Brien, T. Smith, and J. P. Dudley, Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas, Cancer Res. 50, 5911-5918 (1990).
74. N. Barnabas-Sohi, M. R. Simha, V. A. Parikh, F. Feiulhade, A. Kurkure, J. C. Kouyoumdjian, D. J. Jussawalla, V. M. Doctor, and A. Therwath, Breast carcinoma in a high-risk population: structural alterations in neu, int-2 and p53 genes, Breast Dis. 6, 13-26 (1993).
75. E. Schuwring, E. Verhoeven, H. van Tinteren, L. Peterse, B. Nunnink, F. B. J. M. Thunnissen, P. Devilee, C. J. Cornelisse, M. J. van de Vijver, and W. J. Mooi, Amplification of genes within chromosome 11q13 region is indicative of poor prognosis with operable breast cancer, Cancer Research 52, 5229-5234 (1992).
76. M-H Champeme, I. Bieche, S. Lizard, and R. Lidereau, Amplification of genes within chromosome 11q13 region is indicative of poor prognosis with operable breast cancer, Genes Chromosomes and Cancer 12, 128-133 (1995).
77. E. L. Huguet, J. A. McMahon, A. P. McMahon, R. Bicknell, and A. L. Harris, Differential expression of human Wnt genes 2,3,4, and 7B in human breast cell lines and normal and disease states of human breast tissue, Cancer Res. 54, 2615-2621 (1994).
78. G. N. Schrauzer and D. Ishmael, Effects of selenium and of arsenic on the genesis of spontaneous mammary tumors in inbred C3H mice, Ann. Clin, and Lab. Sci. 4, 441-447 (1974).
79. G. N. Schrauzer, D. A. White, and C. J. Schneider, Inhibition of the genesis of spontaneous mammary tumors in C3H mice: Effects of selenium and of selenium-antagonistic elements and their possible role in human breast cancer, Bioinorg. Chem. 6, 265-270 (1976).
80. D. Medina and F. Shepherd, Selenium-mediated inhibition of mouse mammary tumorigenesis, Cancer Lett. 8, 241-245 (1980).
81. T. Stewart, S-C J. Tsai, H. Grayson, R. Henderson, and G. Opetz, Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation, The Lancet 346, 796-798 (1995).
82. Y. Wang, J. F. Holland, I. K. Bleiweiss, S. Melana, X. Liu, I. Pelisson, A. Cantarella, K. Stellrecht, S. Mani, and B. G. T. Pogo, Detection of mammary tumor virus env gene-like sequences in human breast cancer, Cancer Res. 55, 5173-5179 (1995).
83. Y. Wang, I. Pelisson, V. Go, J. F. Holland, and B. G. T. Pogo, Identification and expression of MMTV-like sequences in human breast cancer, Proc. Am. Assoc. Cancer Res. 37, 565 (1996).